Get started
Johnson & JohnsonJohnson & JohnsonJohnson & Johnson

Johnson & Johnson

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsForecastsSeasonalsBondsETFs

Live chart


Full chart

Key facts today


Johnson & Johnson (JNJ) has assumed control of the Phase 3 Nanoray-312 head and neck cancer trial, with interim data expected in early 2027.
Analyze the impactAnalyze the impact

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪463.72 B‬ USD
Dividend yield (indicated)
2.70%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
10.44 USD
Net income (FY)
‪14.07 B‬ USD
Revenue (FY)
‪88.82 B‬ USD
Shares float
‪2.41 B‬
Beta (1Y)
0.19

Employees


Employees (FY)
‪139.8 K‬
Change (1Y)
‪+7.9 K‬ +5.99%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About Johnson & Johnson


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Joaquin Duato
Website
jnj.com
Headquarters
New Brunswick
Founded
1887
ISIN
US4781601046
FIGI
BBG000RFSXZ5
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Check out other big names from the same industry as JNJN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


JNJJ
Johnson & Johnson 3.75% 03-MAR-2047
Yield to maturity
5.03%
Maturity date
Mar 3, 2047
US478160CM4
Johnson & Johnson 3.5% 15-JAN-2048
Yield to maturity
5.02%
Maturity date
Jan 15, 2048
US478160BV5
Johnson & Johnson 3.7% 01-MAR-2046
Yield to maturity
5.01%
Maturity date
Mar 1, 2046
US478160CT9
Johnson & Johnson 2.45% 01-SEP-2060
Yield to maturity
5.01%
Maturity date
Sep 1, 2060
US478160CX0
Johnson & Johnson 5.25% 01-JUN-2054
Yield to maturity
5.00%
Maturity date
Jun 1, 2054
US478160CS1
Johnson & Johnson 2.25% 01-SEP-2050
Yield to maturity
4.99%
Maturity date
Sep 1, 2050
JNJB
Johnson & Johnson 4.5% 05-DEC-2043
Yield to maturity
4.86%
Maturity date
Dec 5, 2043
US478160BA1
Johnson & Johnson 4.85% 15-MAY-2041
Yield to maturity
4.80%
Maturity date
May 15, 2041
US478160CR3
Johnson & Johnson 2.1% 01-SEP-2040
Yield to maturity
4.77%
Maturity date
Sep 1, 2040
US478160AT1
Johnson & Johnson 5.85% 15-JUL-2038
Yield to maturity
4.67%
Maturity date
Jul 15, 2038
US478160AV6
Johnson & Johnson 4.5% 01-SEP-2040
Yield to maturity
4.64%
Maturity date
Sep 1, 2040

See all JNJN bonds 

ETFs


VTI
Vanguard Total Stock Market ETF
Weight
0.69%
Market value
‪14.05 B‬
USD
VOO
Vanguard S&P 500 ETF
Weight
0.78%
Market value
‪11.00 B‬
USD
IVV
iShares Core S&P 500 ETF
Weight
0.79%
Market value
‪5.64 B‬
USD
SPY
SPDR S&P 500 ETF Trust
Weight
0.80%
Market value
‪5.52 B‬
USD
SPY
SPDR S&P 500 ETF
Weight
0.80%
Market value
‪5.52 B‬
USD
VTV
Vanguard Value ETF
Weight
1.92%
Market value
‪4.01 B‬
USD
XLV
Health Care Select Sector SPDR Fund
Weight
8.75%
Market value
‪3.23 B‬
USD
VIG
Vanguard Dividend Appreciation ETF
Weight
2.07%
Market value
‪2.40 B‬
USD
VYM
Vanguard High Dividend Yield Index ETF
Weight
2.14%
Market value
‪1.74 B‬
USD
GSPX
iShares Core S&P 500 UCITS ETF
Weight
0.81%
Market value
‪1.10 B‬
USD
0A3D
iShares Core S&P 500 UCITS ETF
Weight
0.81%
Market value
‪1.10 B‬
USD

Explore more ETFs 

Sparks


Curated watchlists where JNJN is featured.

See all sparks 

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on TURQUOISE exchange Johnson & Johnson stocks are traded under the ticker JNJN.
We've gathered analysts' opinions on Johnson & Johnson future price: according to them, JNJN price has a max estimate of 240.00 USD and a min estimate of 155.00 USD. Watch JNJN chart and read a more detailed Johnson & Johnson stock forecast: see what analysts think of Johnson & Johnson and suggest that you do with its stocks.
Yes, you can track Johnson & Johnson financials in yearly and quarterly reports right on TradingView.
Johnson & Johnson is going to release the next earnings report on Jan 21, 2026. Keep track of upcoming events with our Earnings Calendar.
JNJN earnings for the last quarter are 2.80 USD per share, whereas the estimation was 2.76 USD resulting in a 1.54% surprise. The estimated earnings for the next quarter are 2.53 USD per share. See more details about Johnson & Johnson earnings.
Johnson & Johnson revenue for the last quarter amounts to ‪23.99 B‬ USD, despite the estimated figure of ‪23.76 B‬ USD. In the next quarter, revenue is expected to reach ‪24.15 B‬ USD.
JNJN net income for the last quarter is ‪5.15 B‬ USD, while the quarter before that showed ‪5.54 B‬ USD of net income which accounts for −6.95% change. Track more Johnson & Johnson financial stats to get the full picture.
Yes, JNJN dividends are paid quarterly. The last dividend per share was 1.30 USD. As of today, Dividend Yield (TTM)% is 2.64%. Tracking Johnson & Johnson dividends might help you take more informed decisions.
Johnson & Johnson dividend yield was 3.40% in 2024, and payout ratio reached 84.80%. The year before the numbers were 3.00% and 84.93% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 25, 2025, the company has ‪139.8 K‬ employees. See our rating of the largest employees — is Johnson & Johnson on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Johnson & Johnson EBITDA is ‪31.15 B‬ USD, and current EBITDA margin is 31.71%. See more stats in Johnson & Johnson financial statements.
Like other stocks, JNJN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Johnson & Johnson stock right from TradingView charts — choose your broker and connect to your account.